Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the CAS number 188062-50-2 , is a crucial drug utilized in the treatment of HIV disease . Its mechanism of action involves inhibiting reverse transcription , a vital protein for viral replication . Patients receiving this substance must undergo genetic screening prior to commencement, due to a risk of hypersensitivity reaction linked to the HLA-B*57:01 allele. This complication can range from mild rash to a severe, life-threatening emergency. Careful monitoring and patient informing are therefore essential for safe and successful utilization of abacavir compound.

Abarelix: Understanding Compound 183552-38-7

Abarelix, also known as compound 183552-38-7, is a laboratory-created decapeptide formulated for the therapy of benign prostatic hyperplasia . This drug functions as a specific gonadotropin-releasing hormone (GnRH) inhibitor, effectively suppressing androgen production. Research into the substance has ALISKERIN HEMIFUMARATE 173334-58-2 focused on its ability to reduce associated conditions and potentially give an alternative to invasive interventions. The molecular profile of 183552-38-7 is complex , showcasing a unique amino acid sequence resulting in its targeted mechanism of impact. Additional clinical research are ongoing to fully assess its long-term well-being and effectiveness .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone acetate is a copyrightal inhibitor of CYP17A1, an enzyme crucial for androgen biosynthesis. Its molecular formula is C26H30O3, and it’s widely identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing the identifier for precise identification. The compound's properties include high affinity for CYP17A1, resulting in reduced androgen concentrations and exhibiting certain white to off-white powder appearance. Further analysis using analytical techniques is usually conducted to verify identity and purity .

CAS Number Spotlight: Abacavir Sulfate Salt – The CAS 188062-50-2

This piece highlights on a significant pharmaceutical ingredient : Abacavir Sulfate , identified by its distinct Chemical Abstracts Service (CAS) registry : 188062-50-2. It is a essential component in the management of HIV infection, frequently prescribed in combination other antiviral drugs. Knowing this identification code is important for professionals in the pharmaceutical industry .

Key points regarding Abacavir Sulfate Form:

  • Purpose: Serves as a nucleoside reverse transcriptase blocker .
  • Use : Generally used in the HIV treatment .
  • Identification : The chemical code 188062-50-2 offers accurate identification .

Investigating Abarelix: Chemical Profile (183552-38-7)

Abarelix, identified by the specific identifier 183552-38-7, represents a fascinating illustration within the realm of hormone study. Its sophisticated arrangement is crucial to its therapeutic activity. Broadly, this molecule is a synthetic hormone antagonist, designed to target and antagonize gonadotropin-releasing GnRH hormone. The organic formula reveals a sequence of building blocks carefully positioned to obtain a specific interaction with the GnRH location.

  • Additional studies are conducted to fully reveal its mode of effect.
  • Understanding its creation is vital for increasing generation.
  • The precise sequence dictates its potency.

Abiraterone Salt (154229-18-2): Applications and Chemical Characteristics

{Abiraterone Salt , with the CAS number 154229-18-2, is a pharmaceutical primarily employed in the management of metastatic gland tumor, specifically those exhibiting mutations in the protein pathway. It functions as an blocker of cytochrome P450c17, an enzyme accountable for androgen creation. Chemically, it’s a synthetic compound with a complex structure , designed to effectively reduce androgen levels. Its medical application has significantly advanced outcomes for patients with advanced prostate malignancy.

Leave a Reply

Your email address will not be published. Required fields are marked *